Chronic and/or overactivation of the inflammasome and resulting increase in IL-6 expression result in poor outcomes in colon cancer patients by activating STAT3 (Corvinus et al. 2005; Slattery et al. 2007; Xiong et al. 2008). Here, IL6 is linked to malignant colon neoplasm.